These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1944433)

  • 1. Interferon gamma for chronic granulomatous disease.
    Mouy R; Seger R; Bourquin JP; Veber F; Blanche S; Griscelli C; Fischer A
    N Engl J Med; 1991 Nov; 325(21):1516-7. PubMed ID: 1944433
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic granulomatous disease with recombinant gamma interferon.
    Goddard EA; Hughes EJ; Duys PJ; Hoffman EB; Beatty DW
    S Afr Med J; 1992 Jan; 81(2):81-3. PubMed ID: 1733029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic-cell transplantation for chronic granulomatous disease.
    Thrasher A; Goldblatt D
    N Engl J Med; 2001 Aug; 345(5):377-8. PubMed ID: 11484708
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on chronic granulomatous disease: the concept of the near-normal host.
    Ezekowitz RA
    Curr Clin Top Infect Dis; 2000; 20():325-34. PubMed ID: 10943531
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.
    Ezekowitz RA; Dinauer MC; Jaffe HS; Orkin SH; Newburger PE
    N Engl J Med; 1988 Jul; 319(3):146-51. PubMed ID: 2838754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked chronic granulomatous disease: more than two years later.
    Orkin SH
    Mol Biol Med; 1989 Feb; 6(1):1-5. PubMed ID: 2502702
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experiences with interferon-alpha and interferon-gamma.
    Steinmann GG; Rosenkaimer F; Leitz G
    Int Rev Exp Pathol; 1993; 34 Pt B():193-207. PubMed ID: 8458713
    [No Abstract]   [Full Text] [Related]  

  • 8. [Occurrence of chronic granulomatous disease must be surveyed--new treatment exists].
    Palmblad J; Gyllenhammar H; Ringertz B; Elinder G; Lidefelt KJ; Ahlin A; Smith E; Hammarström L
    Lakartidningen; 1991 Feb; 88(7):508-9, 511. PubMed ID: 1900341
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in the treatment of patients with chronic granulomatous disease.
    Weening RS; Verhoeven AJ; de Boer M; Roos D
    Acta Paediatr Hung; 1988-1989; 29(1-2):223-7. PubMed ID: 3151262
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
    Rex JH; Bennett JE; Gallin JI; Malech HL; DeCarlo ES; Melnick DA
    J Infect Dis; 1991 Apr; 163(4):849-52. PubMed ID: 1901332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern management of chronic granulomatous disease.
    Seger RA
    Br J Haematol; 2008 Feb; 140(3):255-66. PubMed ID: 18217895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of systemic lupus erythematosus in a young child affected with chronic granulomatous disease following withdrawal of treatment with interferon-gamma.
    Badolato R; Notarangelo LD; Plebani A; Roos D
    Rheumatology (Oxford); 2003 Jun; 42(6):804-5. PubMed ID: 12771442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic granulomatous disease, 1992].
    Fontán Casariego G
    Med Clin (Barc); 1992 May; 99(1):24-6. PubMed ID: 1602895
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic granulomatous disease: an update and a paradigm for the use of interferon-gamma as adjunct immunotherapy in infectious diseases.
    Ezekowitz RA
    Curr Top Microbiol Immunol; 1992; 181():283-92. PubMed ID: 1424784
    [No Abstract]   [Full Text] [Related]  

  • 16. Conventional versus interferon-gamma therapy in chronic granulomatous disease.
    Curnutte JT
    J Infect Dis; 1993 Mar; 167 Suppl 1():S8-12. PubMed ID: 8433018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term interferon-gamma therapy for patients with chronic granulomatous disease.
    Marciano BE; Wesley R; De Carlo ES; Anderson VL; Barnhart LA; Darnell D; Malech HL; Gallin JI; Holland SM
    Clin Infect Dis; 2004 Sep; 39(5):692-9. PubMed ID: 15356785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma in the management of chronic granulomatous disease.
    Gallin JI
    Rev Infect Dis; 1991; 13(5):973-8. PubMed ID: 1962114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.
    Slack MA; Thomsen IP
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S25-S30. PubMed ID: 29746681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE. Case report.
    Kantar A; Oggiano N; Gabbianelli R; Fabrizzi G; Giorgi PL
    Minerva Pediatr; 1994 Apr; 46(4):157-60. PubMed ID: 8084323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.